⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethoxycarbonyl Group SCHEMBL28330943 | 0.78 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL24309289 | 0.73 | — | — | |
| SCHEMBL383108 | 0.72 | — | — | |
| SCHEMBL196153 | 0.72 | — | — | |
| SCHEMBL29895688 | 0.72 | — | — | |
| SCHEMBL7964419 | 0.72 | UHRF1 (0.42) | — | |
| SCHEMBL2174027 | 0.70 | — | — | |
| Ammonia Solution, Strong SCHEMBL7855111 | 0.70 | — | — | |
| Phosphine SCHEMBL29249462 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL8589457 | 0.70 | GRM4 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590071-B2 | Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-03-31 | — | — | US | disclosed |
| WO-2025264959-A1 | SUBSTITUTED PYRAZOLOPYRIDINES AS PHOSPHOINOSIDIDE KINASE (PIK) MODULATORS | RECURSION PHARMACEUTICALS, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| EP-4648853-A1 | TARGETED DEGRADATION OF VAV1 | Monte Rosa Therapeutics AG (CH) | 2025-11-19 | — | — | EP | disclosed |
| EP-4585265-A2 | HETEROARYL INHIBITORS OF PLASMA KALLIKREIN | Takeda Pharmaceutical Company Limited (JP) | 2025-07-16 | — | — | EP | disclosed |
| US-20250205219-A1 | TARGETED DEGRADATION OF VAV1 | MONTE ROSA THERAPEUTICS AG (CH) | 2025-06-26 | — | — | US | disclosed |
| CN-115850263-B | 2, 7-Disubstituted benzothiazole compound and application thereof | 浙江工业大学 | 2025-06-17 | — | — | CN | disclosed |
| EP-4061813-B1 | PYRROLIDINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2025-06-04 | — | — | EP | disclosed |
| US-20250171439-A1 | INDOLIN-2-ONE OR PYRROLO -PYRIDIN -2 -ONE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2025-05-29 | — | — | US | disclosed |
| WO-2025103465-A1 | NITROGEN-CONTAINING HETEROARYL DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE | 上海齐鲁制药研究中心有限公司 | 2025-05-22 | — | — | WO | disclosed |
| US-12257247-B2 | Targeted degradation of VAV1 | MONTE ROSA THERAPEUTICS AG (CH) | 2025-03-25 | — | — | US | disclosed |
| US-5216134-A | Using two different chelates as probes | WALLAC OY (FI) | 1993-06-01 | — | — | US | disclosed |
| US-5208239-A | Plant fungicides | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-05-04 | — | — | US | disclosed |
| US-5185339-A | FUNGICIDAL COMPOUNDS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-02-09 | — | — | US | disclosed |
| WO-1992008714-A1 | PYRIDIL-PYRIMIDINE DERIVATIVES AS FUNGICIDAL COMPOUNDS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-05-29 | — | — | WO | disclosed |
| CN-1058019-A | FUNGICIDAL COMPOUNDS | ICI PLC (GB) | 1992-01-22 | — | — | CN | disclosed |
| EP-0459662-A1 | Fungicidal compounds | ZENECA LIMITED (GB) | 1991-12-04 | — | — | EP | disclosed |
| EP-0357731-A1 | A NOVEL SPECTROFLUOROMETRIC METHOD AND COMPOUNDS THAT ARE OF VALUE FOR THE METHOD. | WALLAC OY (FI) | 1990-03-14 | — | — | EP | disclosed |
| WO-1989008263-A1 | A NOVEL SPECTROFLUOROMETRIC METHOD AND COMPOUNDS THAT ARE OF VALUE FOR THE METHOD | WALLAC OY (FI) | 1989-09-08 | — | — | WO | disclosed |
| US-4627871-A | Herbicidal 2-[4-substituted carboxyamino-phenoxy (or phenyl mercapto)]-substituted pyrimidines | BAYER AKTIENGESELLSCHAFT (DE) | 1986-12-09 | — | — | US | disclosed |
| EP-0168608-A2 | Substituted carboxylic-acid anilides | BAYER AG (DE) | 1986-01-22 | — | — | EP | disclosed |